Navigation Links
Innovative Digital Pathology Solutions to be Unveiled at CAP '11
Date:9/1/2011

TUCSON, Ariz., Sept. 1, 2011 /PRNewswire/ -- Ventana Medical Systems, Inc., (Ventana) a member of the Roche Group, will unveil its newest digital pathology solution designed to increase efficiency and throughput in today's anatomic pathology laboratories. The new product will be unveiled at the College of American Pathologists (CAP) 2011 annual meeting on Sept. 11, 2011, at 12:12 pm in Ventana booth # 105.

The real promise associated with the transition to digital pathology is an evolution from where labs are today – with pathologists using digital pathology products for specific applications – to a future where pathology labs have digitized processes and workflow coupled with digital imaging-enabled diagnostic solutions.

"Digital pathology itself will continue to evolve through improvements in core technologies, such as scanning speed and image resolution, and also by the increasing adoption of specific digital imaging applications in pathology labs across the world," says Dr. Eric Walk, senior vice president and chief medical officer at Ventana.  

CAP '11 will be held at the Gaylord Texan Resort, Grapevine, Texas, from Sept. 11 – 14, 2011.  Visit Ventana at booth #105 to learn more about the latest advancements in the area of digital pathology.

About Ventana Medical Systems, Inc.
Ventana Medical Systems, Inc. ("VMSI") (SIX: RO, ROG; OTCQX: RHHBY), a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company's "Smart Systems" – intuitive, integrated staining and workflow management platforms that optimize laboratory efficiencies to reduce errors – support diagnosis and inform treatment decisions for anatomic pathology professionals. Together with Roche, VMSI is driving personalized medicine through accelerated drug discovery and the development of "companion diagnostics" to identify the patients most likely to respond favorably to specific therapies. Visit www.ventana.com to learn more.

VENTANA and the VENTANA logo are trademarks of Roche.

For further information, please contact:

Jacqueline Bucher

Director, Corporate Communications

520-877-7288

jacquie.bucher@ventana.roche.com





'/>"/>
SOURCE Ventana Medical Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
2. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
3. Oculus Innovative Sciences to Present at 4th Annual BIO InvestorForum Conference
4. Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients
5. Raydiance Collaborates With Rutgers University and Nations Largest Tissue Bank to Develop Innovative Tissue Processing Approaches
6. YMed, Inc. Successfully Completes First Clinical Cases With Innovative VascuTraK(TM) II PTA Dilatation Catheter
7. Innovative Brain Scanning for Alzheimers Screening Unveiled
8. Gates Foundation Seeks Proposals for Innovative Global Health Research
9. In Blood Vessel Stents, Innovative Materials Allow Better Control, Delivery of Gene Therapy
10. Studies of an Innovative Catheter Ablation System for Atrial Fibrillation Reveal Excellent Outcomes, Safety Profile and Fast Procedure Times
11. CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... the "Global Biosimilar Pipeline and Market Prospects: Addressing ... report to their offering. ... "Global Biosimilar Pipeline and Market ... by Design" provides an in-depth assessment of the current ...
(Date:4/20/2017)... WOONSOCKET, R.I. , April 20, 2017 /PRNewswire/ ... (NYSE: CVS), today unveiled a new store design ... new assortment of healthier food, health-focused products and ... the store to help customers discover new offerings. ... represent the next evolution of the customer experience ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2014 ... ... US$ 7,167.6 Mn in 2015, and is expected to reach ... 5.6% from 2016 to 2024. The global ...
Breaking Medicine Technology:
(Date:4/21/2017)... ... April 21, 2017 , ... RadSite™, ... serve on its Accreditation and Standards Committees to support the organization’s quality ... image quality and reducing patient radiation dose,” reports Eliot Siegel, MD, RadSite’s ...
(Date:4/21/2017)... City, UT (PRWEB) , ... April 21, 2017 , ... ... solutions, recently partnered with Advanced Patient Care of Utah (APCUT) and has appointed Rex ... for the next chapter of growth for our agency and our ability to provide ...
(Date:4/21/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, wrote ... global crisis with solution to peace plan. Yisrayl says war has never brought peace and ... by the Creator Himself. , Yisrayl says war drums are beating all over the ...
(Date:4/21/2017)... ... , ... During April 21-23, Super-Sod will join the vendor market of the ... everyone — from the avid gardener to the landscape admirer — during the three-day ... in a grand venue, and we are certainly looking forward to participating in this ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... news for older shoulder replacement patients; post-operative recovery just might be even better ... of patients presenting with osteoarthritis following surgery: 262 patients under 65 and 103 ...
Breaking Medicine News(10 mins):